## Abstract Bradykinin receptors are differentially expressed in the coronary vascular endothelium of rat and human hearts during the pathogenesis of heart failure, but the mechanisms responsible for this regulation have remained vague. Here we show by quantitative real‐time PCR, Western blot analy
Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells
✍ Scribed by Dah-Yuu Lu; Yuk-Man Leung; Ssu-Ming Huang; Kar-Lok Wong
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 389 KB
- Volume
- 110
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Bradykinin is produced and acts at the site of injury and inflammation. Recent reports have also shown that bradykinin selectively modulates blood–tumor barrier permeability. However, the molecular mechanisms and pathologic roles underlying bradykinin‐induced glioma migration remain unclear. Glioma is the most common primary adult brain tumor, with a poor prognosis because of the ease with which tumor cells spread to other regions of the brain. In this study, we found that bradykinin increases the cell migration and expression of cyclo‐oxygenase‐2 (COX‐2) in glioma cells. Bradykinin‐mediated migration was attenuated by the selective COX‐2 inhibitor NS‐398. Moreover, increased motility of glioma cells and expression of COX‐2 were mimicked by a bradykinin B1 receptor (B1R) agonist and markedly inhibited by a B1R antagonist. Bradykinin‐mediated migration was attenuated by phosphoinositide 3‐kinase (PI‐3 kinase)/AKT inhibitors LY 294002 and wortmannin. Bradykinin stimulation also increased the phosphorylation of the p85 subunit of PI‐3 kinase and serine 473 of AKT. Treatment of bradykinin with AP‐1 inhibitors Tanshinone IIA and curcumin also reduced COX‐2 expression and glioma cell migration. Moreover, treatment of bradykinin also induced phosphorylation of c‐Jun in glioma cells. AP‐1 promoter analysis in the luciferase reporter construct showed that bradykinin increased AP‐1 transcription activity and was inhibited by LY 294002 and wortmannin. One mechanism underlying bradykinin‐directed migration is transcriptional up‐regulation of COX‐2 and activation of the B1R receptor, PI‐3 kinase, AKT, c‐Jun, and AP‐1 pathways. J. Cell. Biochem. 110: 141–150, 2010. © 2010 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Bradykinin (BK) and angiotensin II (AngII) often have opposite roles in cardiovascular diseases. Our aim here was to construct hybrid receptors which bind AngII but signal as BK. Various sequences of the intracellular face of the AngII type I receptor, AT1R, were replaced with correspon
## Abstract The expression of matrix metalloproteinase‐9 (MMP‐9) has been implicated in progression of atherosclerotic lesions. The role and importance of the signaling pathway in the transcriptional regulation of MMP‐9 in human aortic smooth muscle cells (HASMC) was examined. Tumor necrosis factor
## Abstract ## Objective To examine the roles of STATs 1 and 3 in CCL2 production in human osteoblastic cells and their influences on arthritis development. ## Methods The expression of CCL2 in primary human osteoblasts and U2OS human osteoblastic cells was examined by Northern blotting and enzy